(May 24, 2012) – Pradaxa, a blood thinning drug which the U.S. Food and Drug Administration (FDA) is investigating for causing serious, possible fatal bleeding in patients. Doctors prescribe Pradaxa to help reduce strokes and...
Pradaxa
Pradaxa came on the American market after approval by the United States Food and Drug Administration (FDA) in October 2010. It is an anticoagulant drug designed to treat individuals diagnosed with atrial fibrillation, or irregular heartbeat, by...
Pradaxa MDL Judge Imposed $1 Million Fine to Boehringer
In Illinois, the judge overseeing the federal Pradaxa multidistrict litigation (MDL) has imposed nearly $1 million in sanctions on Pradaxa drug maker Boehringer Ingelheim, saying the company’s failure to produce or preserve thousands of...